cGxP.wire https://validator.w3.org/feed/docs/rss2.html Trialt and Viedoc Advance Digital Clinical Trial Efficiency Regeneron Wins FDA Nod for EYLEA HD Extended Dosing Regeneron Partners with TriNetX for 300M Patient Data Merck Launches Phase 2b/3 Trial for AMD Eye Therapy Ultragenyx Advances UX016 Into Clinical Trials for GNEM AvenCell Therapeutics Advances Next-Gen CAR-T Therapy Glycomine Advances GLM101 Into Phase 2b Rare Disease Trial Triple Hair Group Advances TH07 Into Phase III Trial Panoramic Launches Cardio-Renal Clinical Research Institute AstraZeneca Reports Imfinzi Combo Success in Liver Cancer Cipla Wins FDA Approval for IPF Drug Nintedanib Ultragenyx Advances UX111 Gene Therapy Toward Approval Revolution Medicines Advances Daraxonrasib Into Phase 3 Cogent Biosciences Files NDA for Bezuclastinib in GIST Merck Wins EU Approval for KEYTRUDA Combo in Ovarian Cancer Deupirfenidone Shows Strong IPF Results in Phase 2b Study Intelligent Bio Advances FDA 510(k) Drug Test Program Thermo Fisher Launches Compleo System for Cell Therapy Axsome Acquires Balipodect to Expand CNS Drug Pipeline AskBio Completes Phase 2 Enrollment for Heart Failure Gene Therapy Caris Launches ChromoSeq for Myeloid Cancer Profiling Hoth HT-001 Meets Endpoint, Expands Phase 2 Trial in EU Sanofi Rezurock Wins EU Approval for Chronic GvHD Frontier Licenses p53 Cancer Drug FMC-220 to LG Chem Agenus Showcases Phase II Cancer Immunotherapy Data at AACR Ocugen Completes Dosing in Phase 2/3 Stargardt Trial Merck Partners Infinimmune in $838M Antibody Discovery Deal Samsung Biologics Acquires GSK U.S. Manufacturing Site Ambrosia Biosciences Raises $100M for GLP-1 Pipeline Johnson & Johnson INLEXZO Gets J-Code for Cancer Access Pasithea Wins FDA Fast Track for PAS-004 Cancer Drug GSK Wins China Approval for Exdensur in Severe Asthma Rapport Presents Phase 2 Data for Epilepsy Drug RAP-219 MaaT Pharma CHRONOS Data Reveals Poor aGvHD Survival Abbisko Irpagratinib Gains EMA Orphan Drug Status Recordati Confirms CVC Interest in Major Pharma M&A Deal Anixa Advances Breast Cancer Vaccine to Phase 2 Trial FDA Approves Lilly Foundayo Oral GLP-1 Weight Loss Drug Biogen to Acquire Apellis in $5.6B Strategic Pharma Deal Tiziana Life Sciences Nasal Therapy Boosts Brain Health Cardinal Health Expands Ac-225 Supply for Cancer Therapies Lilly to Acquire Centessa in $7.8B Pharma Deal Rigel GAVRETO Shows Strong Survival in NSCLC Trial BioXcel IGALMI sNDA Accepted by FDA for At-Home Use Enveric Biosciences Gains U.S. Patent for EVM301 i-Lumen Advances AMD Trial With FDA IDE Approval JenaValve Launches Trilogy Valve for Aortic Regurgitation Lupin Gains FDA Nod for Sugammadex Injection in US Bristol Myers Camzyos Shows Strong Results in HCM Trial Earendil Labs Advances HXN-1001 Into Phase IIa Trial